| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons RT Chung, J Andersen, P Volberding, GK Robbins, T Liu, KE Sherman, ... New England Journal of Medicine 351 (5), 451-459, 2004 | 1142 | 2004 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1081 | 2019 |
| Response-guided telaprevir combination treatment for hepatitis C virus infection KE Sherman, SL Flamm, NH Afdhal, DR Nelson, MS Sulkowski, ... New England Journal of Medicine 365 (11), 1014-1024, 2011 | 1050 | 2011 |
| Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group KE Sherman, SD Rouster, RT Chung, N Rajicic Clinical infectious diseases 34 (6), 831-837, 2002 | 996 | 2002 |
| Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America PH Masur, JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 849 | 2002 |
| Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 832 | 2015 |
| Hepatitis C virus infection in USA: an estimate of true prevalence E Chak, AH Talal, KE Sherman, ER Schiff, S Saab Liver international 31 (8), 1090-1101, 2011 | 526 | 2011 |
| Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1 DL Wyles, PJ Ruane, MS Sulkowski, D Dieterich, A Luetkemeyer, ... New England Journal of Medicine 373 (8), 714-725, 2015 | 521 | 2015 |
| Mechanism of indinavir-induced hyperbilirubinemia SD Zucker, X Qin, SD Rouster, F Yu, RM Green, P Keshavan, J Feinberg, ... Proceedings of the National Academy of Sciences 98 (22), 12671-12676, 2001 | 316 | 2001 |
| The clinical and physiological spectrum of interferon‐alpha induced thyroiditis: toward a new classification JC Mandac, S Chaudhry, KE Sherman, Y Tomer Hepatology 43 (4), 661-672, 2006 | 303 | 2006 |
| Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer SD Zucker, PS Horn, KE Sherman Hepatology 40 (4), 827-835, 2004 | 291 | 2004 |
| HIV/hepatitis C coinfection natural history and disease progression MD Hernandez, KE Sherman Current Opinion in HIV and AIDS 6 (6), 478-482, 2011 | 285 | 2011 |
| Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections KE Sherman, J O'brien, AG Gutierrez, S Harrison, M Urdea, P Neuwald, ... Journal of Clinical Microbiology 31 (10), 2679-2682, 1993 | 270 | 1993 |
| Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial MS Sulkowski, KE Sherman, DT Dieterich, M Bsharat, L Mahnke, ... Annals of internal medicine 159 (2), 86-96, 2013 | 262 | 2013 |
| Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127 MG Peters, J Andersen, P Lynch, T Liu, B Alston‐Smith, CL Brosgart, ... Hepatology 44 (5), 1110-1116, 2006 | 249 | 2006 |
| Alanine aminotransferase in clinical practice: a review KE Sherman Archives of internal medicine 151 (2), 260-265, 1991 | 245 | 1991 |
| Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences JT Blackard, N Kemmer, KE Sherman Hepatology 44 (1), 15-22, 2006 | 244 | 2006 |
| End-stage liver disease in persons with hemophilia and transfusion-associated infections JJ Goedert, ME Eyster, MM Lederman, T Mandalaki, P De Moerloose, ... Blood, The Journal of the American Society of Hematology 100 (5), 1584-1589, 2002 | 229 | 2002 |
| Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy BL Bleau, CJ Gostout, KE Sherman, MJ Shaw, WV Harford, RF Keate, ... Gastrointestinal endoscopy 56 (1), 1-6, 2002 | 228 | 2002 |
| Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine M Bessesen, D Ives, L Condreay, S Lawrence, KE Sherman Clinical infectious diseases 28 (5), 1032-1035, 1999 | 222 | 1999 |
